大手製薬会社の物語 - バイエル (IG ファーベン)、FDA、そしてエイズウイルス
バイエルは、同社がHIVに汚染された血液を血友病患者に販売し、その後数千人がエイズで死亡したという30年にわたるスキャンダルを終わらせるために数億ドルを支払った。
ミロス ポキミカ
によって書かれた: ミロス ポキミカ
医学的に検証した結果 Xiùying Wáng, M.D. 博士。
2023年8月4日更新数十年前、富裕層の病気と動物性食品の消費との関連性はすべて栄養科学によって説明されました。私たちの最大の要因のほとんどは予防可能ですが、現在のビジネスラインを変えることに興味はありません。利用可能な科学はすべて一般公開されなくなりますが、実際にはそれは問題ではありません。
ほとんどの人が気づいているのは単なるプロパガンダです。医者は優秀です、ヒポクラテスの誓いを立てなければなりません、あなたを癒し、助けてくれる存在がいます、そしてもちろん、いつか薬が私たちをあらゆる病気から救ってくれるでしょう。通常、人々が大手製薬会社の背後にある本当の歴史に直面し、次のような真実に気づくとき、 government itself has a network for suppressing the science and that individual men’s interest is not its primary goal, 彼らはたいてい、それはすべて過去のことだと言います。今日、私たちは政府の管理などが強化され、より多くの民主主義と自由を手に入れています。
答えはいいえだ。私たちの自由は第二次世界大戦後よりもさらに少なくなっています。私たちは学校や社会統制のための心理学研究を注入されたメディアによって洗脳されてきましたが、それ以外は何も変わりません。同じ構造は中世だけでなくそれ以前から存在し、存在している。
I will give one more recent example. You’d probably never know that Bayer (IG Farben) paid “tens of millions” of dollars to end a three-decade-long scandal in which the company sold HIV-contaminated blood products to hemophiliacs, thousands of whom later died of AIDS. Bayer is eventually forced into signing checks to individuals that acquired AIDS because, in the 1980s, the Cutter Biological section of Bayer neglected federal law and recruited gay men with high risk and intravenous drug users, and prisoners as donors of the blood that Cutter later used to produce Factor VIII and IX. It is a drug, the clotting product, that hemophiliacs need in order to not bleed to death. In 1997 Bayer was sentenced to pay 600 million into a compensation fund for hemophiliacs with HIV. About 20,000 individuals caught HIV from the blood.
Ironically, Bayer’s new hemophilia iPhone app got some coverage, as did Bayer’s hemophilia research grant to the University of Florida.
1982 年 7 月 16 日、米国疾病管理予防センター (CDC) は、3 人の血友病患者がエイズに感染したと示唆しました。疫学者らは、ウイルスが週に1回注射する血友病治療薬を介して広がっていると考え始めた。医薬品は、さまざまな人々から提供された血漿の大きなプールから作られました。その多くはHIV検査が義務付けられる前に、多くの場合同性愛者や麻薬使用者、一部の刑務所で集められたものだ。感染検査がなければ、血漿提供者がウイルスを保有しているかどうかを判断する方法がありませんでした。1983年1月、バイエルのカッター生物学部門のマネージャーは書簡の中で次のように認めた。
“There is strong evidence to suggest that AIDS is passed on to other people through … plasma products.”
These letters surfaced in trials and were found by some of the investigative journalists that later broke the story public. By May 1983, a Cutter competitor started producing a heat-treated concentrate that killed the virus, so France for example, and many other countries decided to halt all clotting concentrate imports. Cutter worried about losing consumers, so according to an enclosed memo: “want to give the impression that we continue improving our product without telling them that soon we were also going to have a heat-treated” concentrate. By June 1983, a Cutter letter to distributors to 20 countries said that:
“AIDS has become the center of irrational response in many countries” and that “This is of particular concern to us because of unsubstantiated speculations that certain blood products may transmit this syndrome.”
They lied, and many countries were still using an old concentrate. In February 1984, Cutter became the last of the four major blood product companies to get US approval to sell heated concentrate. They waited as long as possible. Still even after Cutter started to sell the new product, still for several more months, they continued making the old medicine. The reason was that the corporation had several fixed-price contracts and thought that the old product would be cheaper to produce. Bayer officials (responding on behalf of Cutter) responded with another lie: “because some customers doubted the new drug’s effectiveness,” some nations were slow to support registration of the new drug. Then they lied by telling that they had a shortage of plasma, which is used to make the medicine. For example, Taiwan was one country that still received the old HIV-infected drug. Hsu Chien-wen, an official at Taiwan’s health department, told in 2003 that Cutter had not appealed for approval to sell the heated medicine until July 1985. That was for an entire year and a half after doing so in the United States. In Hong Kong, for example, Cutter did not even need approval but only an import license in the 1980s to be able to import and sell the newer product in which normally takes one week. A company meeting notes that:
“There is excess inventory,”
実際、その結果、会社は次のような解決策を講じることになりました。
“Review international markets again to determine if more of this product can be sold.”
Because of the lack of control and corruption Cutter decided to dispose of stockpiles of older HIV-positive drugs to third world countries while selling the new, safer product in the West. If some of the people catch AIDS well, they can take Aspirin for pain. And of course, there are all third world countries, so it is going to go well with eugenic programs of depopulation of the planet. When hemophiliacs in Hong Kong all of the sudden start to test positive for HIV, local physicians raised the question of whether Cutter was dumping “AIDS tainted” medicine into less-developed countries. Cutter rejected the accusation, insisting that older drug had “no severe hazard risk” and was, in fact, the “same fine product we have supplied for years.” Hong Kong did not believe the lie, and when the local distributor asked for the newer product, Cutter responded that all of the new product was going to the US and Europe. For Hong Kong, and other third-world countries they could make an exception for a small amount for the “most vocal patients.” Meaning influential people that could potentially make a problem for them. So if you are a son of a politician, they will give you new safe stuff.
米国食品医薬品局は、このニュースが世間の目に触れないようにすることに協力しました。 Government is not there to protect you and never had been. In May 1985, the FDA’s regulator of blood products, Harry M. Meyer Jr., considering the companies had violated a voluntary arrangement to remove the old drug from the market, called directors of the corporations and directed them to comply. Cutter’s internal notes from their meeting show that Meyer required that the issue is:
“Quietly solved without alerting the Congress, the medical community and the public”
also noted that the FDA wanted the matter solved “quickly and quietly.” Also at that time, Cutter official wrote that:
“It appears there are no longer any markets in the Far East where we can expect to sell substantial quantities of nonheated-treated medicine.”
They sell AIDS-tainted medicine as long as possible with no empathy. The effects of all of this are impossible to calculate because there was no test for HIV, so we do not know how many people were infected with HIV before Cutter began selling its safer medicine or afterward. Cutter also sold the old medicine in Argentina, Indonesia, Japan, Malaysia, and Singapore after February 1984. Cutter shipped more than 100,000 vials of unheated concentrate, worth more than $4 million after it began selling the safer product. The sales continued partly because of Cutter’s desire to deplete stocks of the older medicine, and partly because of fixed-price contracts, for which the company believed the older product would be cheaper to make. U.S. Justice Department had never investigated any corporate executives. Bayer in the past even marketed heroin for children. That is the level of psychopathic nature of these people.
参考文献:
本から選ばれた一節: ポキミカ、ミロス。ビーガンに行きますか?科学の復習パート 2。 Kindle版、アマゾン、2018年。
- McHenry L, Khoshnood M. Blood money: Bayer’s inventory of HIV-contaminated blood products and third world hemophiliacs. Account Res. 2014;21(6):389-400. 土井: 10.1080/08989621.2014.882780。PMID: 24785997。
- ジョセフソン・D・血友病患者が、汚染された血液製剤をめぐりバイエル社に対して訴訟を起こす。BMJ。2003 6 14;326(7402):1286。 土井: 10.1136/bmj.326.7402.1286-g。PMID: 12805147; PMCID: PMC1151015。
関連記事
栄養と健康について何か質問はありますか?
ぜひご意見をいただき、次回の投稿でお答えしたいと思います。皆様のご意見とご意見に感謝しており、すぐにご連絡をお待ちしております。私もあなたを招待します フォローする Facebook、Instagram、Pinterestでダイエット、栄養、健康に関するコンテンツをご覧ください。そこにコメントを残して、他の健康愛好家とつながり、あなたのヒントや経験を共有し、私たちのチームやコミュニティからサポートや励ましを得ることができます。
この投稿があなたにとって有益で楽しいものであり、学んだ洞察を生かす準備ができていることを願っている。この投稿が役に立ったと思われた方は シェアする 友人や家族など、その恩恵にあずかれるかもしれない人たちと一緒に。誰が健康の旅にガイダンスやサポートを必要としているかわからないのですから。
– あなたはおそらくそれも好きでしょう –

栄養について学ぶ
ミロス・ポキミカは、自然医学の医師、臨床栄養士、医療健康と栄養のライター、栄養科学アドバイザーです。書籍シリーズの著者 ビーガンに行きますか?科学の復習また、自然健康サイト「GoVeganWay.com」を運営している。
医療上の免責事項
GoVeganWay.com では、最新の栄養と健康関連の研究のレビューをお届けします。提供される情報は著者の個人的な意見を表すものであり、専門的な医学的アドバイス、診断、または治療に代わることを意図または暗示するものではありません。提供される情報は情報提供のみを目的としており、資格のある医師または医療提供者の相談、診断、および/または治療に代わるものとして機能することを意図したものではありません。GoVeganWay.com で読んだことや GoVeganWay.com を通じてアクセスしたことを理由に、専門家の医学的アドバイスを無視したり、医療治療を受けるのを遅らせたりしないでください。
認可された医師に相談する前に、GoVeganWay.com で読んだ内容の結果としてライフスタイルの変更や変更を決して適用しないでください。
医療上の緊急事態が発生した場合は、直ちに医師または 911 に電話してください。GoVeganWay.com は、内部で言及されている特定のグループ、組織、検査、医師、製品、手順、意見、またはその他の情報を推奨または承認しません。
編集者のおすすめ –
ミロス・ポキミカは、自然医学の医師、臨床栄養士、医療健康と栄養のライター、栄養科学アドバイザーです。書籍シリーズの著者 ビーガンに行きますか?科学の復習また、自然健康サイト「GoVeganWay.com」を運営している。
最新記事 -
プラントベースのニュース
-
‘The Secret Vegan Health Products That No-One Is Talking About’
on 3月 30, 2025
-
Quick Vegan Cucumber Bites
on 3月 29, 2025
-
‘The 4 Healthy Plant-Based Meals I Rely On’
on 3月 29, 2025
-
Vegan Rice Cake Chocolate Bars
on 3月 28, 2025
-
Longevity Expert Says Healthy Diets Should Include Plenty Of Carbs
on 3月 28, 2025
-
Califia Farms Launches New Fruity Drinks Made With Coconut Cream
on 3月 28, 2025
-
Charcoal Spaghetti Carbonara With Vegan Egg Yolk
on 3月 28, 2025
トップヘルスニュース — ScienceDaily
- Researchers identify mutations that can lead to resistance to some chemotherapieson 3月 29, 2025
Investigators have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells. The study found that mutations to VPS35, a key player in this pathway, can prevent chemotherapy-induced cell death. These results could help pinpoint treatment-resistant tumors.
- Discrimination-related depression, anxiety pronounced among multiracial, White, Asian populationson 3月 28, 2025
A new study found that over half of US adults experienced some form of discrimination, and individuals with high exposure to discrimination have more than five times the chances of screening positive for depression, and five times the chances of screening positive for anxiety. Compared to adults who do not experience discrimination, adults who do experience this mistreatment have nearly nine times the odds of screening positive for both depression and anxiety.
- Meniscus injuries may soon be treated by customizable hydrogelon 3月 28, 2025
A new 3D printed customizable hydrogel performed well in preclinical trials with several different types of meniscal tears.
- Cold plunges actually change your cellson 3月 28, 2025
Cold water immersion for seven days significantly improves cellular resilience and autophagic function, helping cells manage stress better. This adaptation could enhance health and longevity, potentially preventing diseases and slowing aging at a cellular level.
- Researchers develop new DNA test for personalized treatment of bacterial vaginosison 3月 28, 2025
Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, and potentially painful side effects, as well as the risk of associated health issues later in life. More than half of the patients who seek medical care do not respond to the first-line treatment, the antibiotic metronidazole, leading to recurrence. Now researchers have developed a simple DNA […]
- Brain channels ‘stopped in time’ reveal chemical flow that enables learning and thinkingon 3月 28, 2025
The finding of a new study could advance the development of new drugs that block or open such signaling channels to treat conditions as varied as epilepsy and some intellectual disorders.
- New approach could treat anthrax beyond the ‘point of no return’on 3月 28, 2025
Researchers show that a cocktail of growth factors reversed would-be lethal cell damage in mice with anthrax, suggesting that this approach could be adapted for use in patients.
パブメッド、 #ビーガンダイエット –
- Effect of Vegan Diet During Greek-Orthodox Religious Fasting on Symptoms of Disorders of Gut-Brain Interactionon 3月 28, 2025
CONCLUSIONS: The results from this representative sample show that a substantial proportion of the Romanian population adheres to Greek-Orthodox fasting. However, in contrast to the a priori hypothesis, we did not have sufficient evidence that religious fasting is associated with the prevalence of DGBI, or with functional gastrointestinal symptoms.
- A vegan dietary pattern is associated with high prevalence of inadequate protein intake in older adults; a simulation studyon 3月 27, 2025
CONCLUSIONS: Replacing animal-based protein sources with plant-based food products in older adults reduces both protein quantity and quality, albeit minimally in non-vegan plant-rich diets. In a vegan scenario, the risk of an inadequate protein intake is imminent.
- Do the Health Benefits of the Mediterranean Diet Increase with a Higher Proportion of Whole Plant-Based Foods?on 3月 26, 2025
PURPOSE OF REVIEW: This review aims to explore the potential health effects of increasing the proportion of whole plant-based foods within a Mediterranean diet (MedDiet), summarize the available evidence, and provide recommendations for future research on this topic.
- Optimization of Spirulina-Enriched Vegan Cake Formulation Using Response Surface Methodologyon 3月 25, 2025
Vegan lifestyle is gaining momentum across the globe due to its environmental effects and health benefits. In parallel with the increasing diet trends, the demand for vegan bakery products is increasing. Since vegan bakery products generally have low protein and bioactive compound content, they have little nutritional contribution to the daily diet of vegan individuals. In light of this, a study was conducted to develop a vegan cake formulation enriched with Spirulina to improve the physical,…
- Plant-based diets and child growthon 3月 25, 2025
PURPOSE OF REVIEW: The EAT-Lancet Commission on Healthy Diets from Sustainable Food Systems recommended a diet that is higher in plant-based food in 2019. Whilst plant-based diets have been followed in many regions of the world, the planetary concern and the published health benefits has increased the uptake of such diets. This review sets out to explore the impact on growth in children following a plant-based diet.
ランダムな投稿 –
おすすめの投稿 -

PubMed の最新情報、 #植物ベースの食事 –
- Replacing cow’s milk with plant-based drinks: consequences for nutrient intake of young children on a balanced diet in Germanyby Mathilde Kersting on 3月 29, 2025
CONCLUSIONS: The lack in important nutritional components (calcium, B12, B2, and iodine) as a consequence of replacement of cow’s milk with most of the plant-based drinks on the current market on nutrient intake of young children can hardly be foreseen by parents. Even minor-looking changes to a balanced diet require an expert opinion of advisors.
- Effect of long-term Mediterranean versus low-fat diet on neutrophil count, and type 2 diabetes mellitus remission in patients with coronary heart disease: results from the CORDIOPREV studyby Hatim Boughanem on 3月 28, 2025
CONCLUSION: These findings suggest that neutrophil count can help in identifying patients that are more likely to achieve T2DM remission following a Mediterranean diet, suggesting a role on insulin sensitivity and β-cell function. Further research holds promise for providing valuable insights into the pathophysiology of T2DM.
- Diversity of dietary protein patterns across Europe – Impact on nutritional quality and environmental sustainabilityby Merel C Daas on 3月 28, 2025
Transitioning from animal-based to plant-rich diets could potentially improve both human and planetary health, but a thorough understanding of the protein component in the diet is essential. This research aimed to identify dietary protein patterns in the European adult population and evaluate differences in nutritional quality and environmental sustainability. Individual-level food consumption data were obtained from 25 European countries (40,101 participants, 18-64 years), available from the…
- Acceptability of a Web-Based Health App (PortfolioDiet.app) to Translate a Nutrition Therapy for Cardiovascular Disease in High-Risk Adults: Mixed Methods Randomized Ancillary Pilot Studyby Meaghan E Kavanagh on 3月 28, 2025
CONCLUSIONS: Although adherence was higher for the PortfolioDiet.app group, no difference in adherence was found between the groups in this small ancillary study. However, this study demonstrates that the PortfolioDiet.app is considered usable by high-risk adults and may reinforce dietitian advice to follow the Portfolio Diet when it is a part of a trial for CVD management.
- Update on cardiovascular prevention 2025by Harm Wienbergen on 3月 28, 2025
Despite an expensive healthcare system Germany performs poorly with respect to life-expectancy compared to other countries, for which cardiovascular diseases and deficits in cardiovascular prevention in particular are responsible. The basis of cardiovascular prevention is a healthy lifestyle with regular physical exercise, a predominantly plant-based diet, nonsmoking, good sleep and mental health. In many cases additional lipid-lowering, antidiabetic and antihypertensive medications are…
- Severe Vitamin B12 deficiency with complications in an elderly patient: a case study of pancytopenia and haemolysisby Mohamed Jayte on 3月 28, 2025
Severe vitamin B12 deficiency can lead to pancytopenia, haemolysis and various systemic manifestations. This case report discussed the case of a 66-year-old male patient who had adhered to a strict vegetarian diet for 5 years and presented with symptoms of fatigue, pallor and leg pain. Laboratory tests revealed severe pancytopenia (haemoglobin 4.8 g/dL, white cell count 2630/µL, platelets 112 000/mm³), macrocytic anaemia (mean cell volume 118 fL) and elevated lactate dehydrogenase (5480 […]